Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
Globe Newswire3-06-2024, 04:07
Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease 17-12-2024, 19:30